ALBIOMA financials
ALBIOMA
Country: FR Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
9695002W8GRJRZ44MA62 Financial statements
(EUR, as reported — unscaled; 101 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | €60.4M | €56.3M |
| Raw materials & consumables used | €183.2M | €139.6M |
| Operating profit (EBIT) | €128.3M | €122.5M |
| Profit before tax | €95.5M | €90.4M |
| Income tax expense | €24.2M | €26.1M |
| Profit for the year | €71.3M | €64.4M |
| — attributable to owners | €59.0M | €55.3M |
| — attributable to NCI | €12.3M | €9.1M |
| Total comprehensive income | €93.4M | €29.7M |
| Per share | ||
| Basic EPS | €1.88 | €1.78 |
| Diluted EPS | €1.83 | €1.72 |
| Cash flow statement | ||
| Cash generated from operations | €217.1M | €209.1M |
| Net cash from operating activities | €174.0M | €173.6M |
| Net cash from investing activities | -€187.0M | -€129.6M |
| Net cash from financing activities | -€3.4M | -€76.3M |
| Dividends paid | €27.4M | €21.3M |
| Proceeds from borrowings | €186.8M | €149.3M |
| Repayments of borrowings | €126.5M | €171.3M |
| Balance sheet | ||
| Total assets | €1.88B | €1.75B |
| Non-current assets | €1.56B | €1.45B |
| Property, plant & equipment | €1.38B | €1.28B |
| Intangible assets & goodwill | €15.6M | €16.9M |
| Current assets | €316.2M | €298.0M |
| Inventories | €75.8M | €60.3M |
| Trade & other receivables | €95.8M | €67.5M |
| Cash & equivalents | €107.9M | €125.8M |
| Total equity | €599.5M | €532.3M |
| — attributable to owners | €502.9M | €442.6M |
| Non-controlling interests | €96.5M | €89.8M |
| Non-current liabilities | €1.01B | €992.4M |
| Long-term borrowings | €860.2M | €822.8M |
| Lease liabilities (non-current) | €40.0M | €36.7M |
| Current liabilities | €269.6M | €226.0M |
| Lease liabilities (current) | €2.0M | €1.8M |
| Deferred tax liabilities | €23.0M | €18.6M |
| Derived metrics | ||
| Operating margin | 22.4% | 24.2% |
| Net margin | 12.4% | 12.7% |
| Return on equity | 11.9% | 12.1% |
| Cash conversion ratio | 2.44× | 2.70× |
| Other reported items | ||
| Adjustments For Deferred Tax Expense | -€3.5M | €964.0K |
| Adjustments For Income Tax Expense | €27.6M | €25.1M |
| Adjustments For Interest Expense | €32.0M | €31.8M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €220.0K | -€64.0K |
| Adjustments For Sharebased Payments | €5.1M | €1.8M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €2.4M | -€840.0K |
| Bank Overdrafts Classified As Cash Equivalents | €0 | €590.0K |
| Cash | €93.2M | €89.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €107.9M | €125.2M |
| Cash Equivalents | €14.7M | €36.8M |
| Comprehensive Income Attributable To Noncontrolling Interests | €15.1M | €1.7M |
| Comprehensive Income Attributable To Owners of Parent | €78.3M | €28.0M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €110.8M | €79.2M |
| Deferred Tax Assets | €2.4M | €2.5M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €18.4M | €14.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €9.0M | €7.3M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€1.0M | -€3.7M |
| Equity and Liabilities | €1.88B | €1.75B |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €6.5M | -€1.2M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €1.6M | -€2.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €28.7M | €23.5M |
| Increase Decrease In Cash and Cash Equivalents | -€17.3M | -€35.9M |
| Increase Decrease In Working Capital | €14.4M | €11.9M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €5.3M | €1.8M |
| Increase Decrease Through Transactions With Owners | -€26.3M | -€17.9M |
| Increase Decrease Through Transfers and Other Changes Equity | €377.0K | — |
| Increase Decrease Through Treasury Share Transactions | -€10.0M | €191.0K |
| Intangible Assets Other Than Goodwill | €90.5M | €93.5M |
| Interest Expense | €32.0M | €31.8M |
| Interest Paid Classified As Financing Activities | €32.0M | €31.8M |
| Investment Accounted For Using Equity Method | €25.7M | €22.8M |
| Issue of Equity | €5.6M | €1.4M |
| Issued Capital | €1.2M | €1.2M |
| Noncurrent Derivative Financial Liabilities | €32.5M | €55.0M |
| Noncurrent Financial Assets | €13.1M | €5.1M |
| Noncurrent Provisions For Employee Benefits | €48.6M | €52.6M |
| Other Comprehensive Income | €22.1M | -€34.7M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €25.4M | -€5.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €6.4M | -€7.8M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €18.9M | -€4.1M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €4.8M | -€5.8M |
| Other Comprehensive Income Net of Tax Hedges of Net Investments In Foreign Operations | -€100.0K | €300.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €17.3M | -€28.9M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €4.8M | -€5.8M |
| Other Current Assets | €36.7M | €44.4M |
| Other Current Liabilities | €22.4M | €31.0M |
| Other Finance Cost | €1.4M | €822.0K |
| Other Finance Income | €710.0K | €534.0K |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€18.0K | -€2.8M |
| Other Longterm Provisions | €3.4M | €6.6M |
| Other Noncurrent Assets | €99.0K | €99.0K |
| Proceeds From Issuing Shares | €5.6M | €1.4M |
| Profit Loss From Continuing Operations | €71.3M | €64.4M |
| Profit Loss From Discontinued Operations | €0 | €0 |
| Purchase of Financial Instruments Classified As Investing Activities | €715.0K | €0 |
| Reserve of Exchange Differences On Translation | -€43.1M | -€41.5M |
| Revenue From Contracts With Customers | €573.3M | €506.7M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | €29.1M | €28.5M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €3.3M | €1.6M |
| Share Premium | €76.6M | €64.8M |
| Trade and Other Current Payables To Trade Suppliers | €91.3M | €71.1M |
Methodology
Every line item above is a fact tagged in ALBIOMA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.